Distinguished Faculty
Meet the scientific, clinical and industry leaders who shaped the 2026 European summit.
2026 faculty
Past speakers
The 2027 faculty will be announced as the programme develops.
William Schmidt, Ph.D.
President
NorthStar Consulting
Lars Arendt-Nielsen, Dr. Med, Ph.D.
Professor, Head of Research Group, Center for Neuroplasticity & Pain
Aalborg University
Lynn Kirkpatrick, Ph.D.
Chief Executive Officer
Ensysce Biosciences
Geert Jan Groeneveld, MD, Ph.D.
Neurologist, Clinical Pharmacologist & Chief Executive Officer
Centre for Human Drug Research
Albert Dahan, MD, Ph.D.
Chief Executive Officer
MediD Consultancy
Irving Wainer, Ph.D.
Chief Scientific Officer
Spirify Pharma
Michael Scherz, Ph.D.
Co-founder, Chief Scientific Officer
Arphamid Therapeutics
Simon Westbrook, Ph.D.
Founder & Chief Executive Officer
Levicept
Nathaniel Katz, MD
President & Chief Scientific Officer
Ein Sof Innovation / Vital Clinical Solutions
Harold Minkowitz, MD
Co-President, Acute & Chronic Pain
Evolution Research Group
David Leiman, MD
Co-President, Acute & Chronic Pain
Evolution Research Group
Mark Field, Ph.D.
Chief Executive Officer & Co-Founder
EptivA Therapeutics
Hao Shang, Ph.D.
Senior Director
Sino Biopharmaceutical
Joe Stauffer, DO, MBA, FAPCR
Chief Medical Officer
PVP Labs
Guido Koopmans, Ph.D.
Chief Scientific Officer
Algiax Pharmaceuticals
James Hackworth, Ph.D.
President, Brand Division
Tris Pharma
Klaus Schaffler, MD
Managing & Medical Director, Chief Executive Officer
Human Pharmacodynamic Research
Frank Bosmans, Ph.D.
Professor, Experimental Pharmacology Research Group
Vrije Universiteit Brussel
Cindy McReynolds, Ph.D.
Co-founder & Chief Executive Officer
EicOsis
Nikita Gamper, Ph.D.
Professor of Neuroscience, School of Biomedical Sciences
University of Leeds
Sebastian Hach
Chief Executive Officer
VERTANICAL